BACKGROUND:Intradialytic hypotension (IDH) is common and is associated with increased morbidity and mortality in chronic hemodialysis patients. A higher dialysis 'dose' may generate transient intradialytic osmotic gradients, predisposing to intracellular fluid shifts and resulting in hypotension. STUDY DESIGN: We performed a post hoc analysis of the HEMO study, a multicenter trial that randomized chronic hemodialysis patients to high versus standard Kt/V and higher versus lower membrane flux. In order to achieve dose targets, per protocol, adjustments were made in membrane efficiency, blood flow or dialysate flow before changing session length. Detailed hemodynamic and urea kinetic modeling data were abstracted from 1,825 individuals. The primary outcome was the occurrence of hypotensive events necessitating clinical intervention (saline infusion, lowering of ultrafiltration rate or reduced blood flow). RESULTS:Intradialytic hypotensive events occurred more frequently in the higher-Kt/V group (18.3 vs. 16.8%; p < 0.001). Participants randomized to higher-target Kt/V had a greater adjusted risk of IDH than those randomized to standard Kt/V [odds ratio (OR) 1.12; 95% confidence interval (CI) 1.01-1.25]. Higher vs. lower dialyzer mass transfer-area coefficient for urea and rate of urea removal were associated with greater adjusted odds of IDH (OR 1.15; 95% CI 1.04-1.27 and OR 1.05; 95% CI 1.04-1.06 per mg/dl/h, respectively). CONCLUSIONS: Higher dialysis dose, at relatively constrained treatment times, may associate with an increased risk of IDH. These findings support the possibility that rapidity of intradialytic reductions in plasma osmolality may play an important role in mediating hemodynamic instability during dialysis.
RCT Entities:
BACKGROUND: Intradialytic hypotension (IDH) is common and is associated with increased morbidity and mortality in chronic hemodialysis patients. A higher dialysis 'dose' may generate transient intradialytic osmotic gradients, predisposing to intracellular fluid shifts and resulting in hypotension. STUDY DESIGN: We performed a post hoc analysis of the HEMO study, a multicenter trial that randomized chronic hemodialysis patients to high versus standard Kt/V and higher versus lower membrane flux. In order to achieve dose targets, per protocol, adjustments were made in membrane efficiency, blood flow or dialysate flow before changing session length. Detailed hemodynamic and urea kinetic modeling data were abstracted from 1,825 individuals. The primary outcome was the occurrence of hypotensive events necessitating clinical intervention (saline infusion, lowering of ultrafiltration rate or reduced blood flow). RESULTS: Intradialytic hypotensive events occurred more frequently in the higher-Kt/V group (18.3 vs. 16.8%; p < 0.001). Participants randomized to higher-target Kt/V had a greater adjusted risk of IDH than those randomized to standard Kt/V [odds ratio (OR) 1.12; 95% confidence interval (CI) 1.01-1.25]. Higher vs. lower dialyzer mass transfer-area coefficient for urea and rate of urea removal were associated with greater adjusted odds of IDH (OR 1.15; 95% CI 1.04-1.27 and OR 1.05; 95% CI 1.04-1.06 per mg/dl/h, respectively). CONCLUSIONS: Higher dialysis dose, at relatively constrained treatment times, may associate with an increased risk of IDH. These findings support the possibility that rapidity of intradialytic reductions in plasma osmolality may play an important role in mediating hemodynamic instability during dialysis.
Authors: Tao Liu; Kelly V Liang; Alan Rosenbaum; Ryan Stephenson; Francis Pike; Lisa Weissfeld; Mark L Unruh Journal: Nephrol Dial Transplant Date: 2012-01-23 Impact factor: 5.992
Authors: Tom Greene; John Daugirdas; Thomas Depner; Michael Allon; Gerald Beck; Cameron Chumlea; James Delmez; Frank Gotch; John W Kusek; Nathan Levin; William Owen; Gerald Schulman; Robert Star; Robert Toto; Garabed Eknoyan Journal: J Am Soc Nephrol Date: 2005-09-28 Impact factor: 10.121
Authors: Tara I Chang; Jane Paik; Tom Greene; Manisha Desai; Fritz Bech; Alfred K Cheung; Glenn M Chertow Journal: J Am Soc Nephrol Date: 2011-08 Impact factor: 10.121
Authors: S van der Zee; A Thompson; R Zimmerman; J Lin; Y Huan; M Braskett; R R Sciacca; D W Landry; J A Oliver Journal: Kidney Int Date: 2006-09-27 Impact factor: 10.612
Authors: Paul J Owen; William S Priestman; Mhairi K Sigrist; Stewart H Lambie; Stephen G John; Lindsay J Chesterton; Christopher W McIntyre Journal: Hemodial Int Date: 2009-05-12 Impact factor: 1.812
Authors: Francesco Locatelli; Sergio Stefoni; Thierry Petitclerc; Luigi Colì; Salvatore Di Filippo; Simeone Andrulli; Christine Fumeron; Giovanni Maria Frascà; Sibilla Sagripanti; Silvana Savoldi; Andrea Serra; Carmine Stallone; Filippo Aucella; Antonio Gesuete; Antonio Scarlatella; Francesco Quarello; Paola Mesiano; Peter Ahrenholz; Roland Winkler; Lise Mandart; Joan Fort; Christian Tielemans; Carlo Navino Journal: Nephrol Dial Transplant Date: 2012-05-04 Impact factor: 5.992
Authors: Johanna Kuipers; Loes M Verboom; Karin J R Ipema; Wolter Paans; Wim P Krijnen; Carlo A J M Gaillard; Ralf Westerhuis; Casper F M Franssen Journal: Am J Nephrol Date: 2019-05-24 Impact factor: 3.754
Authors: Api Chewcharat; Pol Chewcharat; Weitao Liu; Jacqueline Cellini; Elizabeth A Phipps; Jill A Melendez Young; Sagar U Nigwekar Journal: PLoS One Date: 2022-07-14 Impact factor: 3.752
Authors: Finnian R Mc Causland; Katherine Scovner Ravi; Katherine A Curtis; Zoé A Kibbelaar; Samuel A P Short; Anika T Singh; Simon Correa; Sushrut S Waikar Journal: Nephrol Dial Transplant Date: 2022-06-23 Impact factor: 7.186
Authors: Finnian R Mc Causland; Josephine Asafu-Adjei; Rebecca A Betensky; Paul M Palevsky; Sushrut S Waikar Journal: Clin J Am Soc Nephrol Date: 2016-07-22 Impact factor: 8.237
Authors: Philip Andreas Schytz; Maria Lerche Mace; Anne Merete Boas Soja; Brian Nilsson; Nikolaos Karamperis; Bent Kristensen; Søren Daustrand Ladefoged; Henrik Post Hansen Journal: Nephrol Dial Transplant Date: 2015-09-01 Impact factor: 5.992